Brain-computer interfaces are becoming a reality, with over 100 institutions researching 5 concept stocks this year

According to the National Healthcare Security Administration, on March 13, the world's first invasive brain-computer interface medical device was officially approved for market launch. On March 15, the National Healthcare Security Administration proactively connected and provided services to complete the medical insurance coding for this product, successfully facilitating the key link from approval to clinical application for innovative products, marking the transition of the brain-computer interface industry from "planning blueprint" to "fast track." According to data from Data Treasure, since the beginning of this year, 12 brain-computer interface concept stocks have received institutional research. Among them, 5 stocks were investigated by more than 110 institutions, namely Xiangyu Medical, APON, ZKTECO, BIOTEST BIOTECH, and 37 Interactive Entertainment. (Securities Times)